Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/23/2025

Estrogen Therapy for Mood and Anxiety Disorders

Guideline Recommendations

  • The U.S. Preventive Services Task Force recommends against the routine use of hormone therapy, including estrogen, for the primary prevention of chronic conditions in perimenopausal and postmenopausal women 1
  • Hormone therapy should be used primarily for symptom management rather than prevention or treatment of mood disorders 1
  • Mood disorders should be treated with selective serotonin reuptake inhibitors rather than estrogen therapy 2

Cardiovascular and Thrombotic Risks

  • The Women's Health Initiative demonstrated that combined estrogen-progestin therapy increased CHD incidence by 29% (HR: 1.29) and increased risks of stroke and pulmonary embolism 2, 4
  • Women with high risk of venous thromboembolism should avoid HRT entirely 2
  • If HRT is used, transdermal estrogen formulations may have lower rates of venous thromboembolism compared to oral formulations 5

Safe Use of HRT

  • The lowest effective dose for the shortest duration should be used if HRT is prescribed 5, 1
  • Progesterone should not be used alone for chronic condition prevention 5

Mechanistic Understanding

  • Over 50 preclinical studies in rodent models of cerebral ischemia and 22 in vitro neuronal studies have shown neuroprotective effects of estrogen 3